DCOY CIK: 1615219

Decoy Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−31.8
FY23:
−12.9
FY24:
−5.73
FY25:
−12.6
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−12.9
FY24:
−5.73
FY25:
−12.6
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−12.5
FY24:
−5.58
FY25:
−12.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−31.6
FY23:
−12.5
FY24:
−5.58
FY25:
−12.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data